Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |